Role of p38 inhibition in cardiac ischemia/reperfusion injury (English)
- New search for: Kumphune, S.
- New search for: Chattipakorn, S.
- New search for: Chattipakorn, N.
- New search for: Kumphune, S.
- New search for: Chattipakorn, S.
- New search for: Chattipakorn, N.
In:
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
;
68
, 5
;
513-524
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Role of p38 inhibition in cardiac ischemia/reperfusion injury
-
Contributors:
-
Published in:EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY ; 68, 5 ; 513-524
-
Publisher:
- New search for: Springer Science + Business Media
-
Publication date:2012-01-01
-
Size:12 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.1
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 615.1 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 68, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 453
-
Alternative treatments for breast cancerErnst, E. et al. | 2012
- 455
-
Clinical trials during pregnancy: what has been doneDomínguez, V. / Ramos, N. / Torrents, A. / García, D. / Carné, X. et al. | 2012
- 459
-
Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancyGrzeskowiak, L. E. / Gilbert, A. L. / Morrison, J. L. et al. | 2012
- 469
-
Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic reviewLi, J. / Xu, H. / Gao, Q. / Wen, Y. et al. | 2012
- 479
-
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseasesZarogoulidis, P. / Papanas, N. / Kioumis, I. / Chatzaki, E. / Maltezos, E. / Zarogoulidis, K. et al. | 2012
- 505
-
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experienceLerose, R. / Musto, P. / Aieta, M. / Papa, C. / Tartarone, A. et al. | 2012
- 513
-
Role of p38 inhibition in cardiac ischemia/reperfusion injuryKumphune, S. / Chattipakorn, S. / Chattipakorn, N. et al. | 2012
- 525
-
Fluoroquinolone-induced liver injury: three new cases and a review of the literatureLicata, A. / Randazzo, C. / Morreale, I. / Butera, G. / D’Alessandro, N. / Craxì, A. et al. | 2012
- 533
-
Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosisLebrec, D. / Bosch, J. / Jalan, R. / Dudley, F. J. / Jessic, R. / Moreau, R. / Garcia-Pagan, J. C. / Mookerjee, R. P. / Chiossi, E. / Giersbergen, P. L. et al. | 2012
- 543
-
The practical application of adaptive study design in early phase clinical trials: a retrospective analysis of time savingsLorch, U. / Berelowitz, K. / Ozen, C. / Naseem, A. / Akuffo, E. / Taubel, J. et al. | 2012
- 553
-
Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteersZadoyan, G. / Rokitta, D. / Klement, S. / Dienel, A. / Hoerr, R. / Gramatté, T. / Fuhr, U. et al. | 2012
- 561
-
Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysisZhang, S. / Chen, J. / Jiang, H. / Ma, H. / Yang, B. et al. | 2012
- 571
-
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammationMolanaei, H. / Stenvinkel, P. / Qureshi, A. R. / Carrero, J. J. / Heimbürger, O. / Lindholm, B. / Diczfalusy, U. / Odar-Cederlöf, I. / Bertilsson, L. et al. | 2012
- 579
-
Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypesHayato, S. / Hasegawa, S. / Hojo, S. / Okawa, H. / Abe, H. / Sugisaki, N. / Munesue, M. / Horai, Y. / Ohnishi, A. et al. | 2012
- 589
-
Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allograftsReichen, J. r. / Stickel, F. / Bhattacharya, I. / Matschke, K. / Maller, E. / Korth-Bradley, J. et al. | 2012
- 599
-
Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity—application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive controlHan, S. / Lee, J. / Jeon, S. / Hong, T. / Yim, D. S. et al. | 2012
- 607
-
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profileClemens, A. / Ryn, J. / Sennewald, R. / Yamamura, N. / Stangier, J. / Feuring, M. / Härtter, S. et al. | 2012
- 617
-
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriersMlynarsky, L. / Bejarano-Achache, I. / Muszkat, M. / Caraco, Y. et al. | 2012
- 629
-
Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype–phenotype correlation in childhoodGumus, E. / Karaca, O. / Babaoglu, M. O. / Baysoy, G. k. / Balamtekin, N. / Demir, H. / Uslu, N. / Bozkurt, A. / Yuce, A. / Yasar, U. et al. | 2012
- 637
-
CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian populationDorado, P. / Heras, N. / Machín, E. / Hernández, F. / Teran, E. / LLerena, A. n. et al. | 2012
- 645
-
Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokineticsBrennan, M. / Williams, J. A. / Chen, Y. / Tortorici, M. / Pithavala, Y. / Liu, Y. C. et al. | 2012
- 657
-
Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipientsKim, I. W. / Moon, Y. J. / Ji, E. / Kim, K. I. / Han, N. / Kim, S. J. / Shin, W. G. / Ha, J. / Yoon, J. H. / Lee, H. S. et al. | 2012
- 671
-
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantationStratta, P. / Quaglia, M. / Cena, T. / Antoniotti, R. / Fenoglio, R. / Menegotto, A. / Ferrante, D. / Genazzani, A. / Terrazzino, S. / Magnani, C. et al. | 2012
- 681
-
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrationsKaronen, T. / Laitila, J. / Niemi, M. / Neuvonen, P. J. / Backman, J. T. et al. | 2012
- 689
-
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosisGengiah, T. N. / Holford, N. H. / Botha, J. H. / Gray, A. L. / Naidoo, K. / Abdool Karim, S. S. et al. | 2012
- 697
-
Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjectsRebello, S. / Zhao, S. / Hariry, S. / Dahlke, M. / Alexander, N. / Vapurcuyan, A. / Hanna, I. / Jarugula, V. et al. | 2012
- 709
-
Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteersK. P., A. / Meda, V. S. / Kucherlapati, V. S. / Dubala, A. / M., D. / P. R., A. V. / K., E. / B., S. et al. | 2012
- 715
-
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavirJann, M. W. / Spratlin, V. / Momary, K. / Zhang, H. / Turner, D. / Penzak, S. R. / Wright, A. / VanDenBerg, C. et al. | 2012
- 723
-
Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phaseLarson, R. A. / Yin, O. Q. / Hochhaus, A. / Saglio, G. / Clark, R. E. / Nakamae, H. / Gallagher, N. J. / Demirhan, E. / Hughes, T. P. / Kantarjian, H. M. et al. | 2012
- 735
-
Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgeryIsla, A. / Trocóniz, I. a. / Tejada, I. L. / Vázquez, S. / Canut, A. s. / López, J. s. / Solinís, M. a. / Gascón, A. R. et al. | 2012
- 747
-
Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studiesKwok, C. S. / Yeong, J. K. / Turner, R. M. / Cavallazzi, R. / Singh, S. / Loke, Y. K. et al. | 2012
- 757
-
Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysisHoffmann, P. / Keller, F. et al. | 2012
- 767
-
The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in FranceMontastruc, F. / Sommet, A. s. / Bondon-Guitton, E. / Durrieu, G. v. / Bui, E. / Bagheri, H. / Lapeyre-Mestre, M. / Schmitt, L. / Montastruc, J. L. et al. | 2012
- 777
-
What’s in a label? An exploratory study of patient-centered drug instructionsSahm, L. J. / Wolf, M. S. / Curtis, L. M. / Behan, R. / Brennan, M. / Gallwey, H. / Mc Carthy, S. et al. | 2012
- 783
-
Are commonly used psychoactive medications associated with lower urinary tract symptoms?Hall, S. A. / Maserejian, N. N. / Link, C. L. / Steers, W. D. / McKinlay, J. B. et al. | 2012
- 793
-
Implementation of an automated signal detection method in the French pharmacovigilance database: a feasibility studyPizzoglio, V. r. / Ahmed, I. l. / Auriche, P. / Tuber-Bitter, P. / Haramburu, F. o. / Kreft-Jaïs, C. / Miremont-Salamé, G. / French, N. o. et al. | 2012
- 801
-
Risk factors associated with adverse drug reactions in hospitalised children: international multicentre studyRashed, A. N. / Wong, I. C. / Cranswick, N. / Tomlin, S. / Rascher, W. / Neubert, A. et al. | 2012
- 811
-
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?McLay, J. S. / Stewart, D. / George, J. / Rore, C. / Heys, S. D. et al. | 2012
- 821
-
Drug-induced immune thrombocytopaenia: results from the Berlin Case–Control Surveillance StudyGarbe, E. / Andersohn, F. / Bronder, E. / Salama, A. / Klimpel, A. / Thomae, M. / Schrezenmeier, H. / Hildebrandt, M. / Späth-Schwalbe, E. / Grüneisen, A. et al. | 2012
- 833
-
Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosagesBourgeois, J. / Elseviers, M. M. / Azermai, M. / Bortel, L. / Petrovic, M. / Stichele, R. R. et al. | 2012
- 845
-
Effects of personality on use of medications, alcohol, and cigarettes during pregnancyYstrom, E. / Vollrath, M. E. / Nordeng, H. et al. | 2012
- 853
-
Acute toxicity associated with the recreational use of the ketamine derivative methoxetamineWood, D. M. / Davies, S. / Puchnarewicz, M. / Johnston, A. / Dargan, P. I. et al. | 2012
- 857
-
Do Parkinson’s disease patients disclose their adverse events spontaneously?Perez-Lloret, S. / Rey, M. a. / Fabre, N. / Ory, F. / Spampinato, U. / Montastruc, J. L. / Rascol, O. et al. | 2012
- 867
-
Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological studyLochner, S. / Kirch, W. / Schindler, C. et al. | 2012
- 877
-
EMA’s reflection on placebo does not reflect patients’ interestsBertele’, V. / Banzi, R. / Gluud, C. / Garattini, S. et al. | 2012
- 881
-
Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myelomaJena, R. K. / Swain, T. R. / Kansurkar, S. S. / Swain, M. et al. | 2012
- 885
-
Impact of age, gender and haplotypes of thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) genes on 6-mercaptopurine toxicity in children with acute lymphoblastic leukemiaDorababu, P. / Naushad, S. M. / Kutala, V. K. / Digumarti, R. et al. | 2012
- 887
-
Influence of age, sex, and haplotypes of thiopurine methyltransferase (TPMT) gene on 6- mercaptopurine toxicity in children with acute lymphoblastic leukemiaUppugunduri, C. R. / Ansari, M. et al. | 2012
- 889
-
Cholesterol levels, statins, vitamin D, and associated risk of pneumoniaMascitelli, L. / Grant, W. B. / Goldstein, M. R. et al. | 2012
- 891
-
Interaction of flucloxacillin and quinidineComuth, W. J. / Comuth, J. A. / Hauer, R. N. / Malingré, M. M. et al. | 2012
- 895
-
Autoimmune hepatitis induced by adalimumab with successful switch to abataceptGrasland, A. / Sterpu, R. / Boussoukaya, S. / Mahe, I. et al. | 2012
- 899
-
Suspected unexpected adverse effect of sugammadex: hypotensionKokki, M. / Ali, M. / Turunen, M. / Kokki, H. et al. | 2012
- 901
-
Lack of toxicity after paracetamol overdose in a extremely preterm neonatePorta, R. / Sánchez, L. / Nicolás, M. / García, C. / Martínez, M. et al. | 2012